Overview

Somatic Genetic Testing Market Overview:

FutureWise Market Research has instantiated a report that provides an intricate analysis of Somatic Genetic Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Somatic Genetic Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Somatic Genetic Testing Market:
• Agilent Technologies, Inc.
• ARUP Laboratories
• ASURAGEN Inc.
• Beijing Genomics Institute (BGI) Genomics Co., Ltd
• bioMerieux S.A.
• CENTOGENE N.V.
• CIRCULOGENE Theranostics, LLC
• F. Hoffmann-La Roche Ltd.
• Guardant Health, Inc.
• Illumina, Inc.
• Invivoscribe, Inc.
• Laboratory Corporation of America Holdings
• Mission Bio
• NeoGenomics Laboratories, Inc.
• OmniSeq
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Somatic Genetic Testing Market Segmentation:
By Product Type
• Products
   o Kits and Assays
   o Instruments
   o Software
• Services
By Sample
• Tissue-Based
• Blood-Based
• Bone Marrow Aspirates
• Others
By Technology
• Sequencing
   o Next-Generation Sequencing (NGS)
       o Sequencing by Synthesis
       o Other Next-Generation Sequencing Technologies
   o Traditional Sequencing
• Polymerase Chain Reaction
   o Real-Time Polymerase Chain Reaction (RT-PCR)
   o Digital Polymerase Chain Reaction (dPCR)
• Microarray
• Other Technologies
By Application
• Solid Tumors
   o Breast Cancer
   o Prostate Cancer
   o Colorectal Cancer
   o Lung Cancer
   o Liver Cancer
   o Ovarian Cancer
   o Other Solid Tumors
• Hematological Malignancies
   o Leukemia
   o Lymphoma
   o Myeloma
By End User
• Academic and Research Institutions
• Hospitals and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Somatic Genetic Testing Market By Product Type, By Sample, By Technology, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Somatic Genetic Testing Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Somatic Genetic Testing Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Somatic Genetic Testing Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Somatic Genetic Testing Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Products
       7.1.1. Kits and Assays
       7.1.2. Instruments
       7.1.3. Software
  7.4. Services

8. Global Somatic Genetic Testing Market, By Sample Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Tissue-Based
  8.2. Blood-Based
  8.3. Bone Marrow Aspirates
  8.4. Others

9. Global Somatic Genetic Testing Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Sequencing
       9.1.1. Next-Generation Sequencing (NGS)
              9.1.1.1. Sequencing by Synthesis
              9.1.1.2. Other Next-Generation Sequencing Technologies
       9.1.2. Traditional Sequencing
  9.2. Polymerase Chain Reaction
       9.2.1. Real-Time Polymerase Chain Reaction (RT-PCR)
       9.2.2. Digital Polymerase Chain Reaction (dPCR)
  9.3. Microarray
  9.4. Other Technologies

10. Global Somatic Genetic Testing Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
  10.1. Solid Tumors
        10.1.1. Breast Cancer
        10.1.2. Prostate Cancer
        10.1.3. Colorectal Cancer
        10.1.4. Lung Cancer
        10.1.5. Liver Cancer
        10.1.6. Ovarian Cancer
        10.1.7. Other Solid Tumors
  10.2. Hematological Malignancies
        10.2.1. Leukemia
        10.2.2. Lymphoma
        10.2.3. Myeloma

11. Global Somatic Genetic Testing Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  11.1. Academic and Research Institutions
  11.2. Hospitals and Diagnostic Laboratories
  11.3. Pharmaceutical and Biotechnology Companies
  11.4. Contract Research Organizations
  11.5. Other

12. North America Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       12.2.1. U.S.A
       12.2.2. Canada
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         16.2.1. Saudi Arabia
         16.2.2. UAE
         16.2.3. South Africa
         16.2.4. Egypt
   16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4. North America - Market Share Analysis and Key Regional Players
   17.5. Europe - Market Share Analysis and Key Regional Players
   17.6. Asia Pacific - Market Share Analysis and Key Regional Players
   17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   18.1. Agilent Technologies, Inc.
         18.1.1. Company Overview
         18.1.2. Product Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. ARUP Laboratories
         18.2.1. Company Overview
         18.2.2. Product Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. ASURAGEN Inc.
         18.3.1. Company Overview
         18.3.2. Product Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Beijing Genomics Institute (BGI) Genomics Co., Ltd
         18.4.1. Company Overview
         18.4.2. Product Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. bioMerieux S.A.
         18.5.1. Company Overview
         18.5.2. Product Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. CENTOGENE N.V.
         18.6.1. Company Overview
         18.6.2. Product Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. CIRCULOGENE Theranostics, LLC
         18.7.1. Company Overview
         18.7.2. Product Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. F. Hoffmann-La Roche Ltd.
         18.8.1. Company Overview
         18.8.2. Product Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Guardant Health, Inc.
         18.9.1. Company Overview
         18.9.2. Product Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10. Illumina, Inc.
         18.10.1. Company Overview
         18.10.2. Product Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11. Invivoscribe, Inc.
         18.11.1. Company Overview
         18.11.2. Product Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12. Laboratory Corporation of America Holdings
         18.12.1. Company Overview
         18.12.2. Product Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13. Mission Bio
         18.13.1. Company Overview
         18.13.2. Product Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14. NeoGenomics Laboratories, Inc.
         18.14.1. Company Overview
         18.14.2. Product Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15. OmniSeq
         18.15.1. Company Overview
         18.15.2. Product Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview          
   18.16. Oxford Nanopore Technologies Ltd.
         18.16.1. Company Overview
         18.16.2. Product Portfolio
         18.16.3. SWOT Analysis
         18.16.4. Financial Overview
         18.16.5. Strategic Overview      
   18.17. Pacific Biosciences of California, Inc.
         18.17.1. Company Overview
         18.17.2. Product Portfolio
         18.17.3. SWOT Analysis
         18.17.4. Financial Overview
         18.17.5. Strategic Overview
   18.18. QIAGEN N.V.
         18.18.1. Company Overview
         18.18.2. Product Portfolio
         18.18.3. SWOT Analysis
         18.18.4. Financial Overview
         18.18.5. Strategic Overview
   18.19. Quest Diagnostics Incorporated
         18.19.1. Company Overview
         18.19.2. Product Portfolio
         18.19.3. SWOT Analysis
         18.19.4. Financial Overview
         18.19.5. Strategic Overview
   18.20. Thermo Fisher Scientific Inc.
         18.20.1. Company Overview
         18.20.2. Product Portfolio
         18.20.3. SWOT Analysis
         18.20.4. Financial Overview
         18.20.5. Strategic Overview    

19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures